Cargando…

Development of early warning and rapid response system for patients with novel coronavirus pneumonia (COVID-19): A research protocol

BACKGROUND: Coronavirus disease 2019 (COVID-19) has caused serious damage to public health. COVID-19 has no vaccine or specific therapy; its mortality rate increases significantly once patients deteriorate. Furthermore, intensive monitoring of COVID-19 is limited by insufficient medical resources an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Hua, Huang, Huibin, Xie, Xiaolei, Gao, Jiandong, Wu, Ji, Zhu, Yan, He, Wei, Liu, Jingyuan, Li, Ang, Xu, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447504/
https://www.ncbi.nlm.nih.gov/pubmed/32846843
http://dx.doi.org/10.1097/MD.0000000000021874
_version_ 1783574316248465408
author Zhou, Hua
Huang, Huibin
Xie, Xiaolei
Gao, Jiandong
Wu, Ji
Zhu, Yan
He, Wei
Liu, Jingyuan
Li, Ang
Xu, Yuan
author_facet Zhou, Hua
Huang, Huibin
Xie, Xiaolei
Gao, Jiandong
Wu, Ji
Zhu, Yan
He, Wei
Liu, Jingyuan
Li, Ang
Xu, Yuan
author_sort Zhou, Hua
collection PubMed
description BACKGROUND: Coronavirus disease 2019 (COVID-19) has caused serious damage to public health. COVID-19 has no vaccine or specific therapy; its mortality rate increases significantly once patients deteriorate. Furthermore, intensive monitoring of COVID-19 is limited by insufficient medical resources and increased risks of exposure to medical staff. We therefore aim to build an early warning and rapid response system (EWRRS) to address these problems. METHOD: The research is designed as a prospective cohort study, to verify a dynamic and interactive evaluation system; it includes patient self-reporting, active monitoring, early alarming and treatment recommendations. Adult patients diagnosed with COVID-19 will be recruited from Sept 2020 to Aug 2021 at a tertiary contagious hospital. Patients with life expectancy <48 hours, pregnant or lactating, in immunosuppression states or end-stage diseases will be excluded. The intervention is implementation of EWRRS to detect early signs of clinical deterioration of COVID-19 patients, to provide timely and efficient treatment suggestions by the system. EWRRS can determine the classification and interactive evaluation of patient information; the determination is based on the application of 3 different scenario modules, separately driven by patients, nurses, and physicians. The primary outcome is change in disease severity category after treatment. Secondary outcomes include the proportion of patients with different disease severity types; critical deterioration events; patients who had unplanned transfers to an intensive care unit (ICU) and required critical care interventions; intervals from warning to implementation of clinical interventions; hospital mortality; length of ICU and hospital stay; workload of medical staff and risks of exposure to COVID-19. DISCUSSION: Our hypothesis is that EWRRS provides an example of an early identification, warning, and response system for COVID-19. In addition, EWRRS can potentially be extended to use as a grading metric for general critically ill patients in an ICU setting.
format Online
Article
Text
id pubmed-7447504
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-74475042020-09-04 Development of early warning and rapid response system for patients with novel coronavirus pneumonia (COVID-19): A research protocol Zhou, Hua Huang, Huibin Xie, Xiaolei Gao, Jiandong Wu, Ji Zhu, Yan He, Wei Liu, Jingyuan Li, Ang Xu, Yuan Medicine (Baltimore) 3900 BACKGROUND: Coronavirus disease 2019 (COVID-19) has caused serious damage to public health. COVID-19 has no vaccine or specific therapy; its mortality rate increases significantly once patients deteriorate. Furthermore, intensive monitoring of COVID-19 is limited by insufficient medical resources and increased risks of exposure to medical staff. We therefore aim to build an early warning and rapid response system (EWRRS) to address these problems. METHOD: The research is designed as a prospective cohort study, to verify a dynamic and interactive evaluation system; it includes patient self-reporting, active monitoring, early alarming and treatment recommendations. Adult patients diagnosed with COVID-19 will be recruited from Sept 2020 to Aug 2021 at a tertiary contagious hospital. Patients with life expectancy <48 hours, pregnant or lactating, in immunosuppression states or end-stage diseases will be excluded. The intervention is implementation of EWRRS to detect early signs of clinical deterioration of COVID-19 patients, to provide timely and efficient treatment suggestions by the system. EWRRS can determine the classification and interactive evaluation of patient information; the determination is based on the application of 3 different scenario modules, separately driven by patients, nurses, and physicians. The primary outcome is change in disease severity category after treatment. Secondary outcomes include the proportion of patients with different disease severity types; critical deterioration events; patients who had unplanned transfers to an intensive care unit (ICU) and required critical care interventions; intervals from warning to implementation of clinical interventions; hospital mortality; length of ICU and hospital stay; workload of medical staff and risks of exposure to COVID-19. DISCUSSION: Our hypothesis is that EWRRS provides an example of an early identification, warning, and response system for COVID-19. In addition, EWRRS can potentially be extended to use as a grading metric for general critically ill patients in an ICU setting. Lippincott Williams & Wilkins 2020-08-21 /pmc/articles/PMC7447504/ /pubmed/32846843 http://dx.doi.org/10.1097/MD.0000000000021874 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle 3900
Zhou, Hua
Huang, Huibin
Xie, Xiaolei
Gao, Jiandong
Wu, Ji
Zhu, Yan
He, Wei
Liu, Jingyuan
Li, Ang
Xu, Yuan
Development of early warning and rapid response system for patients with novel coronavirus pneumonia (COVID-19): A research protocol
title Development of early warning and rapid response system for patients with novel coronavirus pneumonia (COVID-19): A research protocol
title_full Development of early warning and rapid response system for patients with novel coronavirus pneumonia (COVID-19): A research protocol
title_fullStr Development of early warning and rapid response system for patients with novel coronavirus pneumonia (COVID-19): A research protocol
title_full_unstemmed Development of early warning and rapid response system for patients with novel coronavirus pneumonia (COVID-19): A research protocol
title_short Development of early warning and rapid response system for patients with novel coronavirus pneumonia (COVID-19): A research protocol
title_sort development of early warning and rapid response system for patients with novel coronavirus pneumonia (covid-19): a research protocol
topic 3900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447504/
https://www.ncbi.nlm.nih.gov/pubmed/32846843
http://dx.doi.org/10.1097/MD.0000000000021874
work_keys_str_mv AT zhouhua developmentofearlywarningandrapidresponsesystemforpatientswithnovelcoronaviruspneumoniacovid19aresearchprotocol
AT huanghuibin developmentofearlywarningandrapidresponsesystemforpatientswithnovelcoronaviruspneumoniacovid19aresearchprotocol
AT xiexiaolei developmentofearlywarningandrapidresponsesystemforpatientswithnovelcoronaviruspneumoniacovid19aresearchprotocol
AT gaojiandong developmentofearlywarningandrapidresponsesystemforpatientswithnovelcoronaviruspneumoniacovid19aresearchprotocol
AT wuji developmentofearlywarningandrapidresponsesystemforpatientswithnovelcoronaviruspneumoniacovid19aresearchprotocol
AT zhuyan developmentofearlywarningandrapidresponsesystemforpatientswithnovelcoronaviruspneumoniacovid19aresearchprotocol
AT hewei developmentofearlywarningandrapidresponsesystemforpatientswithnovelcoronaviruspneumoniacovid19aresearchprotocol
AT liujingyuan developmentofearlywarningandrapidresponsesystemforpatientswithnovelcoronaviruspneumoniacovid19aresearchprotocol
AT liang developmentofearlywarningandrapidresponsesystemforpatientswithnovelcoronaviruspneumoniacovid19aresearchprotocol
AT xuyuan developmentofearlywarningandrapidresponsesystemforpatientswithnovelcoronaviruspneumoniacovid19aresearchprotocol